惠泰医疗 (688617)
APT Medical Inc.
K-Line Chart
No K-line data available
Company NameShenzhen Huite Medical Equipment Co., Ltd.
Listing Date2021-01-07
Issue Price74.46RMB
Registered Capital14103.004910k RMB
Legal RepresentativeGe Hao
Registered AddressRoom 601, Building B, Tongfang Information Port, No. 11 Langshan Road, Songpingshan Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of electrophysiology and vascular interventional medical devices.
Company Profile 深圳惠泰医疗器械股份有限公司是全球领先的心脑血管微创介入医疗器械供应商,是一家集研发、制造和销售于一体的高新技术企业。公司拥有耗材、设备领域完整的产品研发设计、临床、注册等项目团队,每年超过营业额15%的资金投入到创新型产品研发和研发管理平台的建设。公司研发中心已配备各种高端的研发试验、生产和测试等仪器300余台。在电生理电极导管、带止血阀导管鞘、三维设备等心脑血管介入类产品领域具有深厚的技术储备和高端制造能力。目前,深圳惠泰公司已获得五十多项实用新型专利和发明专利。 在中国, 惠泰医疗以卓越的产品品质和优异的服务赢得了众多客户的青睐, 产品通过自身销售团队及经销商已覆盖全国31多个省、市及自治区,上千家医院。 同时,惠泰医疗也放眼于全球市场,产品畅销欧洲、东欧、东南亚等国家和地区,赢得广泛认可。
Stock Details
1. Key Indicators
- Total Shares(W): 14101.38
- Circulating A-Shares(W): 14101.38
- Earnings Per Share(RMB): 4.4200
- Net Assets Per Share(RMB): 21.1952
- Operating Revenue(W RMB): 186743.75
- Total Profit(W RMB): 70575.15
- **Net Profit Attributable to Parent(W RMB) **: 62330.38
- Net Profit Growth Rate(%): 18.02
- Weighted Return on Equity(%): 22.4100
- Operating Cash Flow Per Share(RMB): 4.7940
- Undistributed Profit Per Share(RMB): 14.8499
- Capital Reserve Per Share(RMB): 4.9546
2. Main Business
The main business covers:
- Research, development, production, and sales of electrophysiology and vascular interventional medical devices
3. Company Basic Information
- Company Name: Shenzhen Hui Tai Medical Apparatus Co., Ltd.
- Listing Date: 2021-01-07
- Industry: Special Purpose Equipment Manufacturing
- Address: Room 601, Building B, Tongfang Information Port, No. 11 Langshan Road, Songpingshan Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province
- Website: https://www.aptmed.com.cn/
- Company Profile: On October 24, 2019, Hui Tai Limited held a board meeting and agreed to convert Hui Tai Limited into a joint stock company as a whole, using September 30, 2019 as the reference date. On November 9, 2019, the issuer held the founding meeting and converted as a whole based on the net assets confirmed by the audit report issued by Lixin Certified Public Accountants. On November 21, 2019, the company obtained its business license and is mainly engaged in the research, development, production, and sales of medical devices.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Mindray Technology Holding Co., Ltd. | Corporate Legal Person | 3250.82 | 23.05 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 645.68 | 4.58 |
| 3 | Zhuhai Tongsheng Investment Partnership (Limited Partnership) | Corporate Legal Person | 491.00 | 3.48 |
| 4 | E Fund SSE STAR Market 50 Index ETF | Fund | 305.76 | 2.17 |
| 5 | ChinaAMC SSE STAR Market 50 Index ETF | Fund | 299.21 | 2.12 |
| 6 | Huabao CSI Medical ETF | Fund | 241.96 | 1.72 |
| 7 | E Fund Blue Chip Selected Mixed Securities Investment Fund | Fund | 190.01 | 1.35 |
| 8 | Fullgoal Precision Medicine Flexible Allocation Mixed Securities Investment Fund Class A | Fund | 142.72 | 1.01 |
| 9 | Harvest Emerging Industries Stock Securities Investment Fund | Fund | 115.96 | 0.82 |
| 10 | Harvest Core Growth Mixed Securities Investment Fund Class A | Fund | 93.96 | 0.67 |
5. Concept Sectors
- Margin Trading & Securities Lending
- High Price-to-Book Ratio
- Blue-chip Stock
- Heavily Held by Funds
- Acquisition Target
- Hundred-Yuan Stock
- MSCI Constituent
- Specialized, Refined, Peculiar and New Enterprises
- Non-Cyclical Stock
- SSE 380 Index
- Mid-Cap Growth
- SZSE Growth Index
- STAR Market 50
- STAR Market Bio-health
- SZSE Emerging Composite Index
Remarks
- Data update date: 2025-11-05
- Data source: Public Market Information